213 related articles for article (PubMed ID: 9460083)
1. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY
Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
3. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis.
Lan HY; Yu XQ; Yang N; Nikolic-Paterson DJ; Mu W; Pichler R; Johnson RJ; Atkins RC
Kidney Int; 1998 Jan; 53(1):136-45. PubMed ID: 9453010
[TBL] [Abstract][Full Text] [Related]
4. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Fan JM; Nikolic-Paterson DJ; Yang N; Mu W; Pichler R; Johnson RJ; Atkins RC; Lan HY
Am J Pathol; 1999 Mar; 154(3):833-41. PubMed ID: 10079261
[TBL] [Abstract][Full Text] [Related]
5. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Atkins RC
Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
[TBL] [Abstract][Full Text] [Related]
6. P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity.
Tipping PG; Huang XR; Berndt MC; Holdsworth SR
Eur J Immunol; 1996 Feb; 26(2):454-60. PubMed ID: 8617318
[TBL] [Abstract][Full Text] [Related]
7. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
9. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Lan HY; Bacher M; Yang N; Mu W; Nikolic-Paterson DJ; Metz C; Meinhardt A; Bucala R; Atkins RC
J Exp Med; 1997 Apr; 185(8):1455-65. PubMed ID: 9126926
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis.
Timoshanko JR; Kitching AR; Semple TJ; Holdsworth SR; Tipping PG
J Am Soc Nephrol; 2005 Sep; 16(9):2646-56. PubMed ID: 16033860
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y
J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270
[TBL] [Abstract][Full Text] [Related]
12. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
[TBL] [Abstract][Full Text] [Related]
13. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
14. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
[TBL] [Abstract][Full Text] [Related]
15. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
Phoon RK; Kitching AR; Jones LK; Holdsworth SR
Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
[TBL] [Abstract][Full Text] [Related]
17. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
[TBL] [Abstract][Full Text] [Related]
18. Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis.
Nitta K; Horita S; Okano K; Uchida K; Honda K; Koike M; Sekine S; Itabashi M; Tsukada M; Takei T; Suzuki K; Yumura W; Nihei H
Clin Nephrol; 2001 Dec; 56(6):459-66. PubMed ID: 11770797
[TBL] [Abstract][Full Text] [Related]
19. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury.
Allen AR; McHale J; Smith J; Cook HT; Karkar A; Haskard DO; Lobb RR; Pusey CD
J Immunol; 1999 May; 162(9):5519-27. PubMed ID: 10228033
[TBL] [Abstract][Full Text] [Related]
20. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
Kitching AR; Turner AL; Wilson GR; Edgtton KL; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2004 Sep; 15(9):2373-82. PubMed ID: 15339986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
